We own 178 issued patents (56 in the United States and 122 in foreign countries), and 51 pending patent applications (39 in the United States, 11 pending foreign applications and 1 pending International Patent Cooperation Treaty (PCT) application) directed to our products, services, and technologies, summarized as follows:

United States Foreign/PCT
Description Issued Pending Issued Pending
MASCT (ForeCYTE) 6 1 11 1
Microcatheter (FullCYTE) 19 2 55 0
NextCYTE Test 0 1 0 1
ArgusCYTE Test 1 0 1 0
Intraductal Treatment Program 11 1 34 1
Carbohydrate biomarkers 1 2 3 0
Microendoscopes 18 32 17 9